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Objectives. The general aim was to assess cancer incidence and mortality among the general population of
Chukotka in 19972010 and to compare it with the population of Russia.
Methods. Cancer data were abstracted from the annual statistical reports of the P.A. Hertzen Research
Institute of Oncology in Moscow. The annual number and percent of cases, crude and age-standardized
cancer incidence (ASIR) and mortality (ASMR) rates per 100,000 among men and women in the Chukotka
Autonomous Okrug were determined for the period 19972010 for incidence and 19992010 for mortality.
Two years’ data were aggregated to generate temporal trends during the period. In age-standardization, the
Segi-Doll world standard population used by the International Agency for Research on Cancer was used.
Results. The higher incidence and mortality rate of cancer (all sites combined) among men compared to
women, which was observed in Russia nationally, was reflected also in Chukotka, although the difference
between men and women was not statistically significant. Overall, the patterns of cancer sites are similar
between Chukotka and Russia, with cancer of the lung/trachea/bronchus and stomach occupying the top
ranks among men. Oesophageal cancer is common in Chukotka but not in Russia, whereas prostate cancer is
common in Russia but not in Chukotka. Among women, breast cancer is either the commonest or second
commonest cancer in terms of incidence or mortality in both Chukotka and Russia. Cancer of the lung/
trachea/bronchi ranks higher in Chukotka than in Russia. The rate of cancer incidence and mortality for all
sites combined during the 13-year period was relatively stable in Russia. Dividing the period into two halves,
an increase among both men and women was observed in Chukotka for all sites combined, and also for
colorectal cancer.
Conclusions. This paper presents previously unavailable cancer epidemiological data on Chukotka. They
provide a basis for comparative studies across circumpolar regions and countries. With its small population,
cancer rates in Chukotka tend to be highly unstable and fluctuate widely from year to year. Even when
aggregated over a decade or more, only broad conclusions regarding patterns and trends can be made
regarding some of the commonest cancer sites, or with all sites combined. Chukotka experienced substantial
social and economic dislocations during the period under study, which could conceivably affect risk factor
distribution and the quality of medical care.
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L
ittle information on the epidemiology of cancer
in the Russian Arctic is available in English. This
study is the first assessment of cancer incidence
in the general population of Chukotka during the last
decade.
Materials and methods
Information was collected from the official statistical
collections of the P.A. Hertzen Research Institute of
Oncology in Moscow, which annually publishes a report
entitled ‘‘Malignant neoplasms in Russia (incidence and
mortality)’’ (111), covering the whole of Russia and
its regions, based on reports in the regional oncology
centres.
The number and percent of cases by age, sex and site
were extracted from the reports, covering the 19972010
period for incidence and 19992010 period for mortality.
Sex-specific crude and age-standardized cancer incidence
(ASIR) and mortality (ASMR) rates and their 95% con-
fidence interval (95% CI) for the Chukotka Autonomous
Okrug and the Russian Federation were computed, using
the Segi-Doll world standard population (12) used by
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the International Agency for Research on Cancer. To
establish temporal trends over this period, the number
of cases over 2-year intervals was averaged.
Results
Appendix Tables (IIV) present the average number of
cases, crude and age-standardized rates of cancer by site
in Chukotka and the whole of Russia, among men and
women separately. For all sites combined, the ASIR
among Chukotka men was 277 per 100,000 (95% CI: 185,
378), compared to 211 per 100,000 (95% CI: 150, 288)
among women, which, statistically, is not significantly
different. The ASIR among Russian men (269 per
100,000, 95% CI: 267.5, 269.8) was significantly higher
than among Russian women (193 per 100,000, 95% CI:
192.9, 194.6).
The ASMR among Chukotka men was 200 per
100,000 (95% CI: 114, 286), compared to 129 per
100,000 (95% CI: 70, 189) among women. In the whole
of Russia, the ASMR among men was 188 per 100,000
(95% CI: 187.3, 189.2), considerably higher than among
women, with a rate of 93 per 100,000 (95% CI: 92.9,
94.0).
For both incidence and mortality, the differences
between Chukotka and Russia are not statistically
significant, taking into consideration the small number
of cases in Chukotka and the wide confidence intervals
associated with its rates.
The top 5 ranking cancers in terms of incidence and
mortality among men and women in either Chukotka or
Russia are shown in Table I.
Among men, cancer of the lung/trachea/bronchi and
cancer of the stomach, whether in terms of incidence or
mortality, are predominating in both Chukotka and
Russia. Eosphageal cancer is common in Chukotka but
not in Russia, whereas prostate cancer is common in
Russia but not in Chukotka.
Among women, breast cancer is either the commonest
or second commonest cancer in terms of incidence or
mortality in both Chukotka and Russia. Cancer of the
lung/trachea/bronchi ranks higher in Chukotka than in
Russia.
The rate of cancer incidence for all sites combined
during the 13-year period was relatively stable in Russia
(Fig. 1), while in Chukotka it increased by 80% among
men between the 19972002 and 20032010 periods, and
by 150% among women between the two periods.
For mortality, the rate for all sites combined also
remained stable in Russia, but showed an 85% increase
among men and a doubling among women comparing
the 19992002 and 20032010 periods (Fig. 2).
In terms of individual cancer sites, no single site stands
out as having changed significantly during the study
period in Russia. In Chukotka, there has been a
substantial increase among both men and women in the
rates of some cancers between the two periods: colon
among women (by 150%) and rectum/recto-sigmoid/anus
among men (by 170%).
Discussion
This paper presents epidemiological data on cancer in
one of Russia’s most remote Arctic regions, which have







Percent Rank Percent Rank Percent Rank Percent Rank
Male Male
Lung/trachea/bronchi 26.3 1 22.4 1 Lung/trachea/bronchi 32.0 1 28.9 1
Stomach 12.1 2 11.4 2 Stomach 13.3 2 14.3 2
Lymphoid/HT 6.3 3 4.8 5 Oesophagus 7.3 3 3.3 10
Oesophagus 5.8 4 2.6 11 Liver/bile ducts 6.1 4 3.0 13
Rectum/RS/anus 5.4 5 4.6 6 Rectum/RS/anus 5.3 5 5.1 5
Colon 4.5 7 5.3 4 Colon 5.0 6 5.3 3
Prostate 2.7 9 7.5 3 Prostate 1.4 15 5.3 4
Female Female
Breast 22.7 1 19.7 1 Lung/trachea/bronchi 21.1 1 6.5 4
Lung/trachea/bronchi 9.1 2 4.1 8 Breast 11.6 2 17.0 1
Cervix 9.1 3 5.2 5 Stomach 11.2 3 12.7 2
Colon 7.7 4 6.9 3 Colon 10.4 4 8.9 3
Rectum/RS/anus 5.9 5 4.8 7 Oesophagus 5.5 5 1.2 17
Stomach 5.6 6 7.8 2 Rectum/RS/anus 4.0 8 6.4 5
Uterus 5.0 7 6.8 4 Uterus 4.4 6 4.7 9
Alexey A. Dudarev et al.
2
(page number not for citation purpose)
Citation: Int J Circumpolar Health 2013, 72: 20470 - http://dx.doi.org/10.3402/ijch.v72i0.20470
not been previously available in English publications
outside Russia. They provide a basis for comparative
studies across circumpolar regions and countries.
Cancer mortality is often used as a proxy for incidence
if the latter is not available. Both are available for
Chukotka and Russia. Mortality is a function of both
incidence and survival, which depends on the access to
and quality of health care.
With its small population, cancer rates in Chukotka
tend to be highly unstable and fluctuate widely from year
to year. Even when aggregated over a decade or more
years, only broad conclusions regarding patterns and
trends can be made regarding some of the commonest
cancer sites, or with all sites combined.
Chukotka experienced substantial social and economic
dislocations during the period under study (see Dudarev
et al. in this Special Issue). Such changes could con-
ceivably affect risk factor distribution and the quality
of medical care  which in turn affects not only survival,
but also detection  and thus the cancer morality and
incidence rates. There is also a major re-distribution of
the population, substantially increasing the proportion
of indigenous people within the total regional popula-
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Fig. 2. Age-standardized mortality rates (ASMR per 100,000) of cancer (all sites combined) among men and women in Chukotka and
Russian Federation, 19992010.
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The epidemiology of cancer among Chukotka natives is
the subject of a companion paper in this Special Issue.
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Appendix Table I. Average annual number of cases, percent, crude and age-standardized cancer incidence rates (ASIR) per 100,000
among men in Chukotka and Russian Federation, 19972010
Chukotka Russia
Male Cases/year % Crude ASIR 95% CI Cases/year % Crude ASIR 95% CI
Lips 0.5 0.8 1.4 1.5 04.3 3242.5 1.5 4.8 3.9 3.63.8
Tongue 0.9 1.4 2.9 2.7 07.2 1717.2 0.8 2.6 2.1 22.2
Salivary glands 0.3 0.4 0.9 0.6 01.8 575 0.3 0.9 0.7 0.60.8
Other parts of oral cavity 1 1.6 3.7 6.9 019.7 2637.1 1.2 4 3.2 3.13.3
Oropharynx 0.8 1.2 2.4 4.6 013.9 1681.8 0.8 2.5 2.1 1.92.1
Nasopharynx 0.4 0.7 1.5 1.5 04.3 372.5 0.2 0.6 0.5 0.40.5
Laryngopharynx 0.7 1 2.3 4.5 013 1524.6 0.7 2.3 1.9 1.82
Oesophagus 3.6 5.8 11.9 13.2 028.3 5648.4 2.6 8.5 6.9 6.67
Stomach 7.8 12.1 25.5 47.5 2.388.3 25261.1 11.4 37.8 30.3 29.230
Colon 2.8 4.5 9.5 9 018.1 11836.6 5.3 17.8 14.2 14.114.6
Rectum/RSJ/anus 3.3 5.4 11.8 16.1 037.4 10283.5 4.6 16.6 13.2 13.113.6
Liver/bile ducts 2.1 3.2 7.3 10.1 024.6 3800.1 1.7 5.7 4.6 4.44.7
Pancreas 1.5 2.3 5.4 7.9 021.5 6939.8 3.1 10.4 8.4 8.18.5
Larynx 1.5 2.6 4.7 4 010 6555.6 3 9.8 7.9 7.68
Lung/trachea/bronchi 16.7 26.3 56.2 63.8 24.1106.9 49480.5 22.4 74.2 59.6 5859.1
Bones/cartilages 0.6 0.9 2 4.6 014 1170.5 0.5 1.8 1.6 1.41.6
Skin melanoma 0.5 0.8 1.9 1.2 03.8 2664.5 1.2 4 3.2 3.13.4
Other MSN 1.7 2.6 6 10.2 024.8 20505.7 9.2 30.8 24.7 24.525.2
Connective/other ST 0.4 0.7 1.2 1.2 02.6 1528.1 0.7 2.3 2 1.92.1
Prostate 1.8 2.7 6.3 10.1 024.6 16839 7.5 25.4 20.1 20.521.1
Kidneys 3 4.6 11.2 12.4 028.9 8654.1 3.9 13 10.5 10.511
Urinary bladder 1.8 2.6 6.5 9.5 024.4 9911.3 4.5 14.9 11.9 11.712.2
Brain/CNS 1.1 1.7 3.9 3.4 08.9 3015.3 1.4 4.6 4 44.3
Thyroid gland 0.8 1.1 2.9 2.2 06.2 1191 0.5 1.8 1.4 1.41.6
Lymphoid/HT 3.8 6.3 11.8 10.3 021.8 10690.1 4.8 16.1 14.1 13.914.4
Other sites 4.1 6.5 0 0 0 14013.8 6.3 0 0 0
All sites 63.3 100 214.5 277.3 185.2378.4 221739.3 100 332.8 269 267.5269.8
RSJrectum-sigmoid junction, MSNmalignant skin neoplasm, STsoft tissues, HThematopoietic tissues, CNScentral nervous
system.
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Appendix Table II. Average annual number of cases, percent, crude and age-standardized cancer incidence rates (ASIR) per 100,000
among women in Chukotka and Russian Federation, 19972010
Chukotka Russia
Female Cases/year % Crude ASIR 95% CI Cases/year % Crude ASIR 95% CI
Lips 0.0 0.0 0.0 0.0 00 1063.0 0.4 1.4 0.6 0.60.6
Tongue 0.2 0.3 0.6 0.4 01.3 535.0 0.2 0.7 0.4 0.40.5
Salivary glands 0.1 0.1 0.3 1.1 03.6 524.0 0.2 0.7 0.4 0.40.5
Other parts of oral cavity 0.4 0.8 1.5 2.0 05.9 677.4 0.3 0.9 0.5 0.50.6
Oropharynx 0.3 0.4 0.9 0.6 01.3 195.2 0.1 0.3 0.2 0.20.2
Laryngopharynx 0.0 0.0 0.0 0.0 00 107.2 0.0 0.1 0.1 0.10.1
Oesophagus 1.5 2.9 5.4 9.3 025.2 1747.0 0.7 2.3 1.1 11.1
Stomach 2.9 5.6 10.7 12.3 026.1 19100.5 7.8 24.9 13.0 12.512.9
Colon 4.3 7.7 16.0 18.8 040.2 17046.5 6.9 22.3 11.7 11.612
Rectum/RSJ/anus 3.1 5.9 11.3 13.0 028.7 11803.3 4.8 15.4 8.4 8.38.6
Liver/bile ducts 0.6 1.1 1.9 3.4 09.3 2986.3 1.2 3.9 2.1 22.1
Pancreas 0.6 1.0 2.4 2.6 07.1 6644.2 2.7 8.7 4.4 44.2
Larynx 0.5 0.8 2.1 2.2 06.6 390.2 0.2 0.5 0.3 0.30.3
Lung/trachea/bronchi 4.9 9.1 18.6 24.9 1.951 10079.8 4.1 13.1 7.0 6.87.1
Bones/cartilages 0.3 0.4 0.9 1.2 02.5 923.7 0.4 1.2 1.0 0.91
Skin melanoma 1.1 2.1 3.6 2.3 05.5 4427.8 1.8 5.8 3.7 3.73.9
Other MSN 2.5 4.4 9.3 9.4 020 33018.8 13.3 43.1 21.8 21.722.2
Connective/other ST 0.3 0.6 1.4 1.4 04.5 1690.8 0.7 2.2 1.6 1.51.7
Breast 12.3 22.7 45.4 40.1 1567.7 48852.3 19.7 63.8 40.6 40.741.5
Cervix uteri 4.9 9.1 18.3 17.4 0.136.4 12999.8 5.2 17.0 12.0 11.912.3
Corpus uteri 2.8 5.0 10.2 8.6 019.6 16964.5 6.8 22.1 13.9 13.814.3
Ovaries 2.1 3.9 7.4 9.2 023.5 12192.3 4.9 15.9 10.5 10.310.7
Kidneys 1.3 2.3 5.3 4.6 011.9 6818.3 2.7 8.9 5.5 5.55.8
Urinary bladder 0.5 0.9 2.0 2.2 06.9 2621.6 1.1 3.4 1.7 1.71.8
Brain/CNS 0.3 0.6 1.4 1.3 04.1 2841.3 1.1 3.7 3.1 33.2
Thyroid gland 2.2 3.9 8.2 5.7 013.3 6990.9 2.8 9.1 6.6 6.67
Lymphoid/HT 2.3 4.2 8.3 10.1 024.1 10997.6 4.4 14.4 10.4 10.210.7
Other sites 2.3 4.1 0.0 0.0 00 13608.8 5.5 0.0 0.0 0.0
All sites 54.5 100.0 201.8 211.8 150.4288.5 248091.9 100.0 323.7 192.5 192.9194.6
RSJrectum-sigmoid junction, MSNmalignant skin neoplasm, STsoft tissues, HThematopoietic tissues, CNScentral nervous
system.
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Appendix Table III. Average annual number of deaths, percent, crude and age-standardized cancer mortality rates (ASMR) per 100,000
among men in Chukotka and Russian Federation, 19992010
Chukotka Russia
Male Deaths/year % Crude ASMR 95% CI Deaths/year % Crude ASMR 95% CI
Lips/oral cavity/pharynx 1.8 4.4 6.4 6.9 015.5 7103.9 4.5 10.7 8.6 8.48.8
Oesophagus 3.1 7.3 10.2 13.2 029.8 5247.5 3.3 7.9 6.3 6.26.5
Stomach 5.4 13.3 18.7 41.3 085.3 22389.5 14.3 33.7 26.6 26.227
Small intestine 0.1 0.2 0.3 0.2 00.6 519.3 0.3 0.8 0.6 0.60.7
Colon 2 5 7.1 11.2 028.6 8255.9 5.3 12.4 9.8 9.610
Rectum/RSJ/anus 2.2 5.3 7.7 9.7 024.1 8014 5.1 12.1 9.5 9.39.7
Liver/bile ducts 2.5 6.1 8 11.3 027 4636.5 3 7 5.6 5.45.7
Pancreas 1.5 3.6 5.1 8.2 021.5 7158.5 4.6 10.8 8.6 8.38.8
Other digestive organs 0.2 0.5 0.6 0.3 01 1536.3 1 2.3 1.8 1.71.9
Larynx 1.5 3.6 4.9 6.4 015.2 4914.5 3.1 7.4 5.9 5.76.1
Lung/trachea/bronchi 13.1 32 45.3 61.4 17.997.8 45412.6 28.9 68.3 54.2 53.754.7
Other respiratory organs 0.3 0.7 0.9 0.7 02 1064.7 0.7 1.6 1.3 1.21.4
Bones/cartilages 0.3 0.7 0.7 1.1 02.9 1121.5 0.7 1.7 1.4 1.31.5
Skin melanoma 0.5 1.4 2 1.3 03.9 1335.5 0.9 2 1.6 1.51.7
Other MSN 0 0 0 0 00 757.7 0.5 1.2 0.9 0.81
Connective/other ST 0.6 1.6 2.1 1.7 04.9 1451.3 0.9 2.2 1.8 1.71.9
Prostate 0.5 1.4 2.1 2.6 07 8248.6 5.3 12.4 9.8 9.610
Other male genital organs 0.4 0.9 1.4 1.3 03 710.9 0.5 1.1 0.9 0.80.9
Kidneys 1.1 2.7 4 5 012.9 4841.1 3.1 7.3 5.8 5.76
Urinary bladder 1 2.4 3.5 3.7 07.7 5628.7 3.6 8.5 6.7 6.56.9
Other urinary organs 0 0 0 0 00 355.5 0.2 0.5 0.5 0.40.5
Brain/CNS 0.9 2.2 3.2 2.4 05.7 3098.8 2 4.7 4 3.84.1
Lymphoid/HT 1.4 3.2 4.6 4.6 011.5 7266.6 4.6 10.9 9.1 8.99.4
Other sites 0.7 1.8 0 0 0 5828.6 3.7 0 0 0
All sites 40.9 100 141.1 199.8 113.5286.1 15689.8 100 236 188.3 187.3189.2
RSJrectum-sigmoid junction, MSNmalignant skin neoplasm, STsoft tissues, HThematopoietic tissues, CNScentral nervous
system.
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Appendix Table IV. Average annual number of deaths, percent, crude and age-standardized cancer mortality rates (ASMR) per 100,000
among women in Chukotka and Russian Federation, 19992010
Chukotka Russia
Female Deaths/year % Crude ASMR 95% CI Deaths/year % Crude ASMR 95% CI
Lips/oral cavity/pharynx 0.3 1.1 0.9 0.7 02 1563.2 1.2 2 1.1 1.11.2
Oesophagus 1.4 5.5 5 7.8 019.6 1569.3 1.2 2 0.9 0.91
Stomach 2.9 11.2 10.7 13.4 030.2 16772.4 12.7 21.9 10.9 10.711.1
Small intestine 0.1 0.4 0.4 1 03 612.2 0.5 0.8 0.4 0.40.4
Colon 2.6 10.4 9.8 14.7 031.9 11745.1 8.9 15.4 7.4 7.27.5
Rectum/RSJ/anus 1 4 3.6 4.1 011 8422.8 6.4 11 5.4 5.35.6
Liver/bile ducts 0.9 3.7 3.4 4 09.9 3613.7 2.7 4.7 2.4 2.32.5
Pancreas 0.6 2.6 2.6 3.3 08.5 6834 5.2 8.9 4.4 4.34.5
Other digestive organs 0.3 1 1 1.6 04.7 2691.8 2 3.5 1.7 1.61.8
Larynx 0.3 1 1.1 0.6 01.9 239.5 0.2 0.3 0.2 0.20.2
Lung/trachea/bronchi 5.5 21.1 21 28.8 2.949.1 8555.2 6.5 11.2 5.7 5.65.8
Other respiratory organs 0.1 0.3 0.4 0.7 02.2 597.3 0.5 0.8 0.5 0.40.5
Bones/cartilages 0.1 0.5 0.4 0.6 01.9 819.2 0.6 1.1 0.7 0.60.8
Skin melanoma 0.5 1.6 1.7 1 02.9 1616.1 1.2 2.1 1.2 1.21.3
Other MSN 0.1 0.3 0.4 1.2 03.6 930.8 0.7 1.2 0.6 0.50.6
Connective/other ST 0.3 1.2 1.1 1.4 04.1 1605.9 1.2 2.1 1.3 1.21.4
Breast 3 11.6 11.6 12.6 027.5 22467.4 17 29.3 17.2 1717.4
Cervix uteri 1.1 4.3 4.3 5.7 014.7 6156.8 4.7 8 5.1 4.95.2
Corpus uteri 1.2 4.4 4.5 5.1 012.3 6236.4 4.7 8.1 4.4 4.34.5
Ovaries 0.7 3 2.7 6.3 018 7429.2 5.6 9.7 5.7 5.65.9
Kidneys 0.4 1.2 1.4 1.9 05.1 3035 2.3 4 2.1 22.2
Urinary bladder 0.4 1.5 1.4 2.2 06.5 1390.6 1.1 1.8 0.8 0.70.8
Other urinary organs 0 0 0 0 0 195.3 0.1 0.2 0.1 0.10.2
Brain/CNS 0.5 2 2.3 1.6 04.7 2885.1 2.2 3.8 2.8 2.72.9
Lymphoid/HT 0.7 2.8 2.8 4.4 011.2 7087.3 5.4 9.2 5.8 5.76
Other sites 0.7 3.3 0 0 0 7097.4 5.4 0 0 0
All sites 25.6 100 97 129 69.6188.5 132168.8 100 172.6 93.5 92.994
RSJrectum-sigmoid junction, MSNmalignant skin neoplasm, STsoft tissues, HThematopoietic tissues, CNScentral nervous
system.
Alexey A. Dudarev et al.
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